Cargando…

Structural insights into μ-opioid receptor activation

Activation of the μ-opioid receptor (μOR) is responsible for the efficacy of the most effective analgesics. To understand the structural basis for μOR activation, we obtained a 2.1 Å X-ray crystal structure of the μOR bound to the morphinan agonist BU72 and stabilized by a G protein-mimetic camelid-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Weijiao, Manglik, Aashish, Venkatakrishnan, A. J., Laeremans, Toon, Feinberg, Evan N., Sanborn, Adrian L., Kato, Hideaki E., Livingston, Kathryn E., Thorsen, Thor S., Kling, Ralf, Granier, Sébastien, Gmeiner, Peter, Husbands, Stephen M., Traynor, John R., Weis, William I., Steyaert, Jan, Dror, Ron O., Kobilka, Brian K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4639397/ https://www.ncbi.nlm.nih.gov/pubmed/26245379 http://dx.doi.org/10.1038/nature14886

Ejemplares similares

Crystal structure of the μ-opioid receptor bound to a morphinan antagonist
por: Manglik, Aashish, et al.
Publicado: (2012)

Structure of the δ-opioid receptor bound to naltrindole
por: Granier, Sébastien, et al.
Publicado: (2012)

Structure of the μ Opioid Receptor-G(i) Protein Complex
por: Koehl, Antoine, et al.
Publicado: (2018)

Structure‐Based Evolution of G Protein‐Biased μ‐Opioid Receptor Agonists
por: Wang, Haoqing, et al.
Publicado: (2022)

Measuring ligand efficacy at the mu-opioid receptor using a conformational biosensor
por: Livingston, Kathryn E, et al.
Publicado: (2018)

Applications of molecular replacement to G protein-coupled receptors
por: Kruse, Andrew C., et al.
Publicado: (2013)

Fumaroylamino-4,5-epoxymorphinans and Related Opioids with Irreversible μ Opioid Receptor Antagonist Effects
por: Moynihan, Humphrey A., et al.
Publicado: (2012)

Activation and allosteric modulation of a muscarinic acetylcholine receptor
por: Kruse, Andrew C., et al.
Publicado: (2013)

Adrenaline-activated structure of the β(2)-adrenoceptor stabilized by an engineered nanobody
por: Ring, Aaron M., et al.
Publicado: (2013)

Photochromic Fentanyl Derivatives for Controlled μ‐Opioid Receptor Activation
por: Lahmy, Ranit, et al.
Publicado: (2022)

Selective and Wash‐Resistant Fluorescent Dihydrocodeinone Derivatives Allow Single‐Molecule Imaging of μ‐Opioid Receptor Dimerization
por: Gentzsch, Christian, et al.
Publicado: (2020)

Conformational dynamics of the μ-opioid receptor determine ligand intrinsic efficacy
por: Zhao, Jiawei, et al.
Publicado: (2023)

Opioid Antagonists from the Orvinol Series as Potential Reversal Agents for Opioid Overdose
por: Disney, Alex, et al.
Publicado: (2022)

The novel μ‐opioid receptor agonist PZM21 depresses respiration and induces tolerance to antinociception
por: Hill, Rob, et al.
Publicado: (2018)

Development by Genetic Immunization of Monovalent Antibodies Against Human Vasoactive Intestinal Peptide Receptor 1 (VPAC1), New Innovative, and Versatile Tools to Study VPAC1 Receptor Function
por: Peyrassol, Xavier, et al.
Publicado: (2018)

Synthesis, Radiosynthesis and Biological Evaluation of Buprenorphine‐Derived Phenylazocarboxamides as Novel μ‐Opioid Receptor Ligands
por: Krüll, Jasmin, et al.
Publicado: (2020)

Agonist-selective recruitment of engineered protein probes and of GRK2 by opioid receptors in living cells
por: Stoeber, Miriam, et al.
Publicado: (2020)

Selectively Promiscuous Opioid Ligands: Discovery of High Affinity/Low Efficacy Opioid Ligands with Substantial Nociceptin Opioid Peptide Receptor Affinity
por: Kumar, Vinod, et al.
Publicado: (2014)

Allosteric Nanobodies Reveal the Dynamic Range and Diverse Mechanisms of GPCR Activation
por: Staus, Dean P, et al.
Publicado: (2016)

[(18)F]Fluorophenylazocarboxylates: Design and Synthesis of Potential Radioligands for Dopamine D3 and μ-Opioid Receptor
por: Nebel, Natascha, et al.
Publicado: (2017)

Targeting opioid receptor signaling in depression: do we need selective κ opioid receptor antagonists?
por: Bailey, Sarah J., et al.
Publicado: (2018)

Effects of N-Substitutions on the Tetrahydroquinoline (THQ) Core of Mixed-Efficacy μ-Opioid Receptor (MOR)/δ-Opioid Receptor (DOR) Ligands
por: Harland, Aubrie A., et al.
Publicado: (2016)

Delineating the Ligand–Receptor Interactions That Lead to Biased Signaling at the μ-Opioid Receptor
por: Kelly, Brendan, et al.
Publicado: (2021)

Development of a Bioavailable μ Opioid Receptor (MOPr) Agonist, δ Opioid Receptor (DOPr) Antagonist Peptide That Evokes Antinociception without Development of Acute Tolerance
por: Mosberg, Henry I., et al.
Publicado: (2014)

Quantitative Detection of µ Opioid Receptor: Western Blot Analyses Using µ Opioid Receptor Knockout Mice
por: Kasai, Shinya, et al.
Publicado: (2011)

Human μ Opioid Receptor Models with Evaluation of the Accuracy Using the Crystal Structure of the Murine μ Opioid Receptor
por: Perez-Aguilar, Jose Manuel, et al.
Publicado: (2012)

Development of an antibody fragment that stabilizes GPCR/G-protein complexes
por: Maeda, Shoji, et al.
Publicado: (2018)

Synthesis and Evaluation of Novel Biased μ-Opioid-Receptor (μOR) Agonists
por: Ma, Mengjun, et al.
Publicado: (2019)

C7β-Methyl Analogues of the Orvinols: The Discovery of Kappa Opioid Antagonists with Nociceptin/Orphanin FQ Peptide (NOP) Receptor Partial Agonism and Low, or Zero, Efficacy at Mu Opioid Receptors
por: Cueva, Juan Pablo, et al.
Publicado: (2015)

Exploring pharmacological activities and signaling of morphinans substituted in position 6 as potent agonists interacting with the μ opioid receptor
por: Ben Haddou, Tanila, et al.
Publicado: (2014)

Constrained catecholamines gain β(2)AR selectivity through allosteric effects on pocket dynamics
por: Xu, Xinyu, et al.
Publicado: (2023)

Author Correction: Constrained catecholamines gain β(2)AR selectivity through allosteric effects on pocket dynamics
por: Xu, Xinyu, et al.
Publicado: (2023)

Allosteric coupling from G protein to the agonist binding pocket in GPCRs
por: DeVree, Brian T., et al.
Publicado: (2016)

Discrete GPCR-triggered endocytic modes enable β-arrestins to flexibly regulate cell signaling
por: Barsi-Rhyne, Benjamin, et al.
Publicado: (2022)

Pharmacological Profiles of Oligomerized μ-Opioid Receptors
por: Lee, Cynthia Wei-Sheng, et al.
Publicado: (2013)

μ-Opioid receptor desensitization: homologous or heterologous?
por: Llorente, Javier, et al.
Publicado: (2012)

Neuropsychological Functions of μ- and δ-Opioid Systems
por: Polunina, Anna G., et al.
Publicado: (2013)

How μ-Opioid Receptor Recognizes Fentanyl
por: Vo, Quynh N., et al.
Publicado: (2020)

How μ-Opioid Receptor Recognizes Fentanyl
por: Vo, Quynh N., et al.
Publicado: (2020)

How μ-opioid receptor recognizes fentanyl
por: Vo, Quynh N., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_k83kr8uptd2ff45d2g94pv8j73